These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 15877799

  • 1. Safety of using hepatitis B virus core antibody or surface antigen-positive donors in kidney or pancreas transplantation.
    Akalin E, Ames S, Sehgal V, Murphy B, Bromberg JS.
    Clin Transplant; 2005 Jun; 19(3):364-6. PubMed ID: 15877799
    [Abstract] [Full Text] [Related]

  • 2. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E, Strasser SI, Koorey DJ, Verran D, McCaughan GW.
    Clin Transplant; 2006 Jun; 20(3):369-73. PubMed ID: 16824156
    [Abstract] [Full Text] [Related]

  • 3. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
    Vizzini G, Gruttadauria S, Volpes R, D'Antoni A, Pietrosi G, Filì D, Petridis I, Pagano D, Tuzzolino F, Santonocito MM, Gridelli B.
    Clin Transplant; 2011 Jun; 25(1):E77-81. PubMed ID: 21039887
    [Abstract] [Full Text] [Related]

  • 4. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS, Vierling JM, Colquhoun SD, Arnaout WS, Chan CK, Khanafshar E, Geller SA, Nichols WS, Fong TL.
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [Abstract] [Full Text] [Related]

  • 5. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V, Ingsathit A, Jirasiritham S.
    Transplant Proc; 2009 Jun; 41(1):213-5. PubMed ID: 19249516
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The risks of HBV infection after liver transplantation from HBc antibody positive donor to HBs antibody positive recipient.
    Ikegami T, Taketomi A, Ohta R, Soejima Y, Yoshizumi T, Harada N, Shimada M, Maehara Y.
    Hepatogastroenterology; 2008 Jun; 55(88):2162-5. PubMed ID: 19260497
    [Abstract] [Full Text] [Related]

  • 8. Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients.
    Veroux M, Puliatti C, Gagliano M, Cappello D, Macarone M, Vizcarra D, Spataro M, Di Mare M, Ginevra N, Veroux P.
    Transplant Proc; 2005 Jun; 37(6):2574-5. PubMed ID: 16182748
    [Abstract] [Full Text] [Related]

  • 9. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
    Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F.
    Transplantation; 1995 Jan 27; 59(2):230-4. PubMed ID: 7839446
    [Abstract] [Full Text] [Related]

  • 10. Safe use of livers from donors with positive hepatitis B core antibody.
    Manzarbeitia C, Reich DJ, Ortiz JA, Rothstein KD, Araya VR, Munoz SJ.
    Liver Transpl; 2002 Jun 27; 8(6):556-61. PubMed ID: 12037788
    [Abstract] [Full Text] [Related]

  • 11. Heart transplantation using donors positive for hepatitis.
    Wang SS, Chou NK, Ko WJ, Yu HY, Chen YS, Hsu RB, Huang SC, Chi NH, Tsao CI, Lai MY, Liau CS, Lee YT.
    Transplant Proc; 2004 Oct 27; 36(8):2371-3. PubMed ID: 15561252
    [Abstract] [Full Text] [Related]

  • 12. Lamivudine prophylaxis for hepatitis B virus infection after lung transplantation.
    Shitrit AB, Kramer MR, Bakal I, Morali G, Ben Ari Z, Shitrit D.
    Ann Thorac Surg; 2006 May 27; 81(5):1851-2. PubMed ID: 16631684
    [Abstract] [Full Text] [Related]

  • 13. Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation.
    Lee KW, Lee DS, Lee HH, Kim SJ, Joh JW, Seo JM, Choe YH, Lee SK.
    Transplant Proc; 2004 Oct 27; 36(8):2311-2. PubMed ID: 15561233
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
    Suehiro T, Shimada M, Kishikawa K, Shimura T, Soejima Y, Yoshizumi T, Hashimoto K, Mochida Y, Maehara Y, Kuwano H.
    Liver Int; 2005 Dec 27; 25(6):1169-74. PubMed ID: 16343068
    [Abstract] [Full Text] [Related]

  • 17. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
    Huang YW, Liu CJ, Lai MY, Lee PH, Tsai MK, Wang SS, Lai MK, Kao JH.
    Clin Ther; 2006 Sep 27; 28(9):1327-34. PubMed ID: 17062306
    [Abstract] [Full Text] [Related]

  • 18. Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.
    Skagen CL, Jou JH, Said A.
    Clin Transplant; 2011 Sep 27; 25(3):E243-9. PubMed ID: 21323735
    [Abstract] [Full Text] [Related]

  • 19. Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature.
    Mahboobi N, Tabatabaei SV, Blum HE, Alavian SM.
    Transpl Infect Dis; 2012 Oct 27; 14(5):445-51. PubMed ID: 22970743
    [Abstract] [Full Text] [Related]

  • 20. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.
    Fabrizio F, Bunnapradist S, Martin P.
    J Nephrol; 2002 Oct 27; 15(6):605-13. PubMed ID: 12495272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.